Abstract
The prevalence of ventricular pre-excitation is 0.07–0.2% in the pediatric population. Kent bundle is the most common atrioventricular accessory pathway and Mahaim fiber is relatively rare. Approximately, 30–60% of children with ventricular pre-excitation have onset of atrioventricular reentrant tachycardia. Persistent atrioventricular reentrant tachycardia can lead to tachycardiomyopathy. The anterograde conduction of right accessory pathway might lead to ventricular systolic dyssynchrony which might result in cardiac dysfunction even in patients with no tachycardia onset. This type of dilated cardiomyopathy was named as accessory pathway-induced dilated cardiomyopathy. Antiarrhythmic drugs can be used to acutely terminate tachycardia or taken orally to decrease tachycardia recurrence in the long term. However, antiarrhythmic drugs that can be chosen for children are quite limited. Sotalol has become a new choice. With the maturation of radiofrequency catheter ablation technique, progress in three-dimensional electro-anatomic mapping, use of cryoablation, and accumulation of experience in children with small age and weight, catheter ablation has become the first choice for children with pre-excitation syndrome.
Conclusion: For ventricular pre-excitation co-exists with dilated cardiomyopathy, differential diagnosis of tachycardiomyopathy or accessory pathway-induced dilated cardiomyopathy should be considered. Catheter ablation (radiofrequency and cryoablation) is a relatively safe and effective treatment option and has become the first choice to treat children with ventricular pre-excitation.
What is Known: • Persistent atrioventricular reentrant tachycardia in children can lead to tachycardiomyopathy; • Antiarrhythmic drugs that can be chosen for children are quite limited. | |
What is New: • The anterograde conduction of right accessory pathway (not related to supraventricular tachycardia) might lead to accessory pathway-induced dilated cardiomyopathy. • Catheter ablation (including radiofrequency and cryoablation) has become the first choice for children with pre-excitation syndrome. |
Similar content being viewed by others
Abbreviations
- AP-induced DCM:
-
Accessory pathway-induced dilated cardiomyopathy
- AVRT:
-
Atrioventricular reentrant tachycardia
- CA:
-
Catheter ablation
- EPS:
-
Electrophysiological study
- RFCA:
-
Radiofrequency catheter ablation
- SVT:
-
Supraventricular tachycardia
- TCMP:
-
Tachycardiomyopathy
- VPE:
-
Ventricular pre-excitation
References
Ho SY (2008) Accessory atrioventricular pathways: getting to the origins. Circulation 117(12):1502–1504. https://doi.org/10.1161/CIRCULATIONAHA.107.764035
Lind J (1945) Pre-excitation of the ventricular part of the heart and its occurrence in children. Acta Paediatr 32(15):153–168. https://doi.org/10.1111/j.1651-2227.1945.tb08972.x
Sano S, Komori S, Amano T, Kohno I, Ishihara T, Sawanobori T, Ijiri H, Tamura K (1998) Prevalence of ventricular preexcitation in Japanese school children. Heart 79(4):374–378. https://doi.org/10.1136/hrt.79.4.374
Stasiak A, Niewiadomska-Jarosik K, Kedziora P (2018) Preexcitation syndromes in children and adolescents. Dev Period Med 22(2):179–186
Cai Q, Shuraih M, Nagueh S (2012) The use of echocardiography in Wolff-Parkinson-White syndrome. Int J Cardiovasc Imaging 28(4):725–734. https://doi.org/10.1007/s10554-011-9880-8
Perry JC, Garson A Jr (1990) Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 16(5):1215–1220
Jiang H, Li XM, Li YH, Zhang Y, Liu HJ (2016) Efficacy and safety of radiofrequency catheter ablation of tachyarrhythmias in 123 children under 3 years of age. Pacing Clin Electrophysiol 39(8):792–796. https://doi.org/10.1111/pace.12888
Adao L, Araujo C, Sa A, Silva P, Oliveira M, Goncalves H, Primo J, Gama V (2011) Importance of accessory pathway location in the efficacy and safety of radiofrequency ablation. Rev Port Cardiol 30(1):35–46. https://doi.org/10.1016/j.ahj.2012.10.025
Stasiak A, Niewiadomska-Jarosik K, Kedziora P (2018) Clinical course and treatment of children and adolescents with the preexcitation syndrome - own studies. Dev Period Med 22(2):113–122
Liu Q, Shehata M, Lan DZ, Ehdaie A, Cingolani E, Chugh SS, Fu G, Jiang C, Wang X (2018) Accurate localization and catheter ablation of superoparaseptal accessory pathways. Heart Rhythm 15(5):688–695. https://doi.org/10.1016/j.hrthm.2017.12.025
Nazer B, Walters TE, Dewland TA, Naniwadekar A, Koruth JS, Najeeb Osman M, Intini A, Chen M, Biermann J, Steinfurt J, Kalman JM, Tanel RE, Lee BK, Badhwar N, Gerstenfeld EP, Scheinman MM (2019) Variable presentations and ablation sites for manifest nodoventricular/nodofascicular fibers. Circ Arrhythm Electrophysiol 12(9):e007337. https://doi.org/10.1161/CIRCEP.119.007337
Kottkamp H, Hindricks G, Shenasa H, Chen X, Wichter T, Borggrefe M, Breithardt G (1996) Variants of preexcitation--specialized atriofascicular pathways, nodofascicular pathways, and fasciculoventricular pathways: electrophysiologic findings and target sites for radiofrequency catheter ablation. J Cardiovasc Electrophysiol 7(10):916–930. https://doi.org/10.1111/j.1540-8167.1996.tb00466.x
Olmedo JA, Abello MS, Cannon B, Doiny D, Bonacina J, Moltedo JM (2018) Electrocardiographic characteristics of fasciculo-ventricular accessory pathways in children: a comparative study with right anteroseptal accessory pathways. Arch Cardiol Mex 88(3):212–218. https://doi.org/10.1016/j.acmx.2017.05.003
Moore JP, Patel PA, Shannon KM, Albers EL, Salerno JC, Stein MA, Stephenson EA, Mohan S, Shah MJ, Asakai H, Pflaumer A, Czosek RJ, Everitt MD, Garnreiter JM, McCanta AC, Papez AL, Escudero C, Sanatani S, Cain NB, Kannankeril PJ, Bratincsak A, Mandapati R, Silva JN, Knecht KR, Balaji S (2014) Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy. Heart Rhythm 11(7):1163–1169. https://doi.org/10.1016/j.hrthm.2014.04.023
Li XM, Ge HY, Shi L, Liu XQ, Guo BJ, Li MT, Jiang H, Zhang Y, Liu HY, Zheng XC, Li A, Zhang YY (2017) Multicenter investigation of the correlation between supraventricular tachycardia and tachycardiainduced cardiomyopathy in children. Zhonghua Er Ke Za Zhi 55(9):668–671. https://doi.org/10.3760/cma.j.issn.0578-1310.2017.09.009
Garson A, Gillette P, McNamara D (1981) Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 98(6):875–882. https://doi.org/10.1016/s0022-3476(81)80578-1
Nerheim P, Birger-Botkin S, Piracha L, Olshansky B (2004) Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 110(3):247–252. https://doi.org/10.1161/01.CIR.0000135472.28234.CC
Huizar JF, Ellenbogen KA, Tan AY, Kaszala K (2019) Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73(18):2328–2344. https://doi.org/10.1016/j.jacc.2019.02.045
Kim DY, Kim SH, Ryu KH (2019) Tachycardia induced cardiomyopathy. Korean Circ J 49(9):808–817. https://doi.org/10.4070/kcj.2019.0199
Raymond-Paquin A, Nattel S, Wakili R, Tadros R (2018) Mechanisms and clinical significance of arrhythmia-induced cardiomyopathy. Can J Cardiol 34(11):1449–1460. https://doi.org/10.1016/j.cjca.2018.07.475
Emmel M, Balaji S, Sreeram N (2004) Ventricular preexcitation associated with dilated cardiomyopathy: a causal relationship? Cardiol Young 14(6):594–599. https://doi.org/10.1017/S1047951104006031
Chiu SN, Chang CW, Lu CW, Wu MH (2013) Restored cardiac function after successful resynchronization by right anterior and anteroseptal accessory pathway ablation in Wolff-Parkinson-White syndrome associated dilated cardiomyopathy. Int J Cardiol 163(1):e19–e20. https://doi.org/10.1016/j.ijcard.2012.08.039
Kwon EN, Carter KA, Kanter RJ (2014) Radiofrequency catheter ablation for dyssynchrony-induced dilated cardiomyopathy in an infant. Congenit Heart Dis 9(6):e179–e184. https://doi.org/10.1111/chd.12124
Dai CC, Guo BJ, Li WX, Xiao YY, Jin M, Han L, Dong JZ (2018) The effect of ventricular pre-excitation on ventricular wall motion and left ventricular systolic function. Europace 20(7):1175–1181. https://doi.org/10.1093/europace/eux242
Kwon BS, Bae EJ, Kim GB, Noh CI, Choi JY, Yun YS (2010) Septal dyskinesia and global left ventricular dysfunction in pediatric Wolff-Parkinson-White syndrome with septal accessory pathway. J Cardiovasc Electrophysiol 21(3):290–295. https://doi.org/10.1111/j.1540-8167.2009.01612.x
Liu LB, Zhou CZ, Lin H, Meng LP, Bian C, Zhang Y, Guo HY (2017) Reversal of Wolff-Parkinson-White Syndrome induced dilated cardiomyopathy via resynchronization and subsequent accessory pathway ablation. J Geriatr Cardiol 14(10):654–656
Guo BJ, Dai CC, Li QQ, Li WX, Han L (2019) Hazards of ventricular pre-excitation to left ventricular systolic function and ventricular wall motion in children: analysis of 25 cases. Cardiol Young 29(3):380–388. https://doi.org/10.1017/S1047951118002500
Kim SH, Jeong SI, Huh J, Kang IS, Lee HJ (2013) Amiodarone and catheter ablation as cardiac resynchronization therapy for children with dilated cardiomyopathy and wolff-Parkinson-white syndrome. Korean Circ J 43(1):57–61. https://doi.org/10.4070/kcj.2013.43.1.57
Udink Ten Cate FE, Kruessell MA, Wagner K, Trieschmann U, Emmel M, Brockmeier K, Sreeram N (2010) Dilated cardiomyopathy in children with ventricular preexcitation: the location of the accessory pathway is predictive of this association. J Electrocardiol 43(2):146–154. https://doi.org/10.1016/j.jelectrocard.2009.09.007
Paech C, Flosdorff P, Gebauer R (2012) Pharmacologic cardiac resynchronization of a 1-year-old boy. Pediatr Cardiol 33:1213–1215. https://doi.org/10.1007/s00246-012-0310-z
Suzuki Y, Suzuki T, Imai Y, Inuzuka R, Suzuki T, Nakamura Y, Ono H (2012) An infant with heart failure due to ventricular dyssynchrony and refractory tachycardia caused by a right anterolateral accessory pathway. Cardiology 23(2):108–112. https://doi.org/10.1159/000342052
Sekine M, Masutani S, Imamura T, Iwamoto Y, Muraji S, Yoshiba S, Ishido H, Sumitomo N (2019) Improvement in dyssynchrony with pharmacological ablation of right-sided accessory pathway-induced cardiomyopathy in infants. Int Heart J 60(5):1201–1205. https://doi.org/10.1536/ihj.18-723
Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, Abrams D, Bauersfeld U, Brugada R, Drago F, de Groot N, Happonen JM, Hebe J, Yen Ho S, Marijon E, Paul T, Pfammatter JP, Rosenthal E (2013) Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-arrhythmia working group joint consensus statement. Europace 15(9):1337–1382. https://doi.org/10.1093/europace/eut082
Lewis J, Arora G, Tudorascu DL, Hickey RW, Saladino RA, Manole MD (2017) Acute management of refractory and unstable pediatric supraventricular tachycardia. J Pediatr 181:177–182.e172. https://doi.org/10.1016/j.jpeds.2016.10.051
Dixon J, Foster K, Wyllie J, Wren C (2005) Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child 90(11):1190–1191. https://doi.org/10.1136/adc.2005.077636
Paul T, Pfammatter JP (1997) Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol 18(2):118–126. https://doi.org/10.1007/s002469900129
Porter CJ, Garson AJ, Gillette PC (1983) Verapamil: an effective calcium blocking agent for pediatric patients. Pediatrics 71(5):748–755
Li XM, Zhang Y, Liu HJ, Jiang H, Ge HY, Zhang Y (2017) Efficacy of intravenous sotalol for treatment of incessant tachyarrhythmias in children. Am J Cardiol 119(9):1366–1370. https://doi.org/10.1016/j.amjcard.2017.01.034
Saul JP, Scott WA, Brown S, Marantz P, Acevedo V, Etheridge S, Perry J, Triedman J, Burriss S, Cargo P, Graepel J, Koskelo EK, Wang R (2005) Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation 112(22):3470–3477. https://doi.org/10.1161/CIRCULATIONAHA.105.534149
Bromberg BI, Dick M, Scott WA, Morady F (1989) Transcatheter electrical ablation of accessory pathways in children. Pacing Clin Electrophysiol 12(11):1787–1796. https://doi.org/10.1111/j.1540-8159.1989.tb01865.x
Van Hare GF, Javitz H, Carmelli D, Saul JP, Tanel RE, Fischbach PS, Kanter RJ, Schaffer M, Dunnigan A, Colan S, Serwer G (2004) Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol 15(7):759–770. https://doi.org/10.1046/j.1540-8167.2004.03645.x
Telishevska M, Hebe J, Paul T, Nurnberg JH, Krause U, Gebauer R, Gass M, Balmer C, Berger F, Molatta S, Emmel M, Lawrenz W, Kriebel T, Hessling G (2019) Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: results from the multicenter “CASPED” study. Clin Res Cardiol 108(6):683–690. https://doi.org/10.1007/s00392-018-1397-x
Philip SJ, Kanter RJ, Abrams D, Asirvatham S, Bar-Cohen Y, Blaufox AD, Cannon B, Clark J, Dick M, Freter A, Kertesz NJ, Kirsh JA, Kugler JD, LaPage M, McGowan FX, Miyake CY, Nathan A, Papagiannis J, Paul T, Pflaumer A, Skanes AC, Stevenson WG, Von Bergen N, Zimmerman F (2016) PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm 13(6):e251–e289. https://doi.org/10.1016/j.hrthm.2016.02.009
Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstrom-Lundqvist C, Calkins H, Corrado D, Deftereos SG, Diller G-P, Gomez-Doblas JJ, Gorenek B, Grace A, Ho SY, Kaski J-C, Kuck K-H, Lambiase PD, Sacher F, Sarquella-Brugada G, Suwalski P, Zaza A, European Soc C, Assoc European Paediat C (2020) 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 41(5):655–720. https://doi.org/10.1093/eurheartj/ehz467
Koca S, Pac F, Eris D, Zabun M, Ozeke O, Ozcan F (2018) Electroanatomic mapping-guided pediatric catheter ablation with limited/zero fluoroscopy. Anatol J Cardiol 20(3):159–164. https://doi.org/10.14744/AnatolJCardiol.2018.72687
Swissa M, Birk E, Dagan T, Abby Naimer S, Fogelman M, Einbinder T, Bruckheimer E, Fogelman R (2017) Limited fluoroscopy catheter ablation of accessory pathways in children. J Cardiol 70(4):382–386. https://doi.org/10.1016/j.jjcc.2016.12.018
Ishizu T, Seo Y, Igarashi M, Sekiguchi Y, Machino-Ohtsuka T, Ogawa K, Kuroki K, Yamamoto M, Nogami A, Kawakami Y, Aonuma K (2016) Noninvasive localization of accessory pathways in Wolff-Parkinson-White syndrome by three-dimensional speckle tracking echocardiography. Circ Cardiovasc Imaging 9(6):e004532. https://doi.org/10.1161/CIRCIMAGING.116.004532
Ceresnak SR, Dubin AM, Kim JJ, Valdes SO, Fishberger SB, Shetty I, Zimmerman F, Tanel RE, Epstein MR, Motonaga KS, Capone CA, Nappo L, Gates GJ, Pass RH (2015) Success rates in pediatric WPW ablation are improved with 3-dimensional mapping systems compared with fluoroscopy alone: a multicenter study. J Cardiovasc Electrophysiol 26(4):412–416. https://doi.org/10.1111/jce.12623
Smith G, Clark JM (2007) Elimination of fluoroscopy use in a pediatric electrophysiology laboratory utilizing three-dimensional mapping. Pacing Clin Electrophysiol 30(4):510–518. https://doi.org/10.1111/j.1540-8159.2007.00701.x
Mah DY, Miyake CY, Sherwin ED, Walsh A, Anderson MJ, Western K, Abrams DJ, Alexander ME, Cecchin F, Walsh EP, Triedman JK (2014) The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace 16(2):277–283. https://doi.org/10.1093/europace/eut237
Knackstedt C, Schauerte P, Kirchhof P (2008) Electro-anatomic mapping systems in arrhythmias. Europace 10(Suppl 3):iii28–iii34. https://doi.org/10.1093/europace/eun225
Gulletta S, Vergara P, Gigli L, D’Angelo G, Radinovic A, Melania Barbaro C, Trevisi N, Della Bella P (2019) Usefulness of electroanatomical mapping with contact force monitoring for accessory pathways ablation in pediatric population. Pediatr Cardiol 40(4):713–718. https://doi.org/10.1007/s00246-019-02051-0
Tai CT, Chen SA, Chiang CE, Chang MS (1999) Characteristics and radiofrequency catheter ablation of septal accessory atrioventricular pathways. Pacing Clin Electrophysiol 22(3):500–511. https://doi.org/10.1111/j.1540-8159.1999.tb00478.x
Kugler JD, Danford DA, Houston KA, Felix G (2002) Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras. J Cardiovasc Electrophysiol 13(4):336–341. https://doi.org/10.1046/j.1540-8167.2002.00336.x
Van Hare GF, Javitz H, Carmelli D, Saul JP, Tanel RE, Fischbach PS, Kanter RJ, Schaffer M, Dunnigan A, Colan S, Serwer G (2004) Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia. Heart Rhythm 1(2):188–196. https://doi.org/10.1016/j.hrthm.2004.03.067
Gillette PC, Swindle MM, Thompson RP, Case CL (1991) Transvenous cryoablation of the bundle of His. Pacing Clin Electrophysiol 14(1):504–510. https://doi.org/10.1111/j.1540-8159.1991.tb02821.x
Kirsh JA, Gross GJ, O’Connor S, Hamilton RM (2005) Transcatheter cryoablation of tachyarrhythmias in children: initial experience from an international registry. J Am Coll Cardiol 45(1):133–136. https://doi.org/10.1016/j.jacc.2004.10.049
Drago F, Silvetti MS, De Santis A, Grutter G, Andrew P (2006) Lengthier cryoablation and a bonus cryoapplication is associated with improved efficacy for cryothermal catheter ablation of supraventricular tachycardias in children. J Interv Card Electrophysiol 16(3):191–198. https://doi.org/10.1007/s10840-006-9028-2
Bravo L, Atienza F, Eidelman G, Ávila P, Pelliza M, Castellanos E, Loughlin G, Datino T, Torrecilla EG, Almendral J, Sánchez PL, Arenal Á, Martínez-Alzamora N, Fernández-Avilés F (2018) Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: systematic review of the literature and meta-analyses. Europace 20(8):1334–1342. https://doi.org/10.1093/europace/eux269
Tanidir IC, Ozyilmaz I, Unsal S, Guzeltas A, Ergul Y (2015) Catheter ablation of the anteroseptal accessory pathway from the non-coronary aortic cusp in a pediatric patient. Anatol J Cardiol 15(3):259–260. https://doi.org/10.5152/akd.2015.5937
Swissa M, Birk E, Dagan T, Fogelman M, Einbinder T, Bruckheimer E, Goldenberg I, Klempfner R, Kirsh JA, Fogelman R (2015) Cryotherapy ablation of parahisian accessory pathways in children. Heart Rhythm 12(5):917–925. https://doi.org/10.1016/j.hrthm.2015.01.042
Xu G, Liu T, Liu E, Ye L, Shehata M, Wang X, Li G (2015) Radiofrequency catheter ablation at the non-coronary cusp for the treatment of para-hisian accessory pathways. Europace 17(6):962–968. https://doi.org/10.1093/europace/euu271
Jiang H, Li XM (2018) Cryoablation of the right anteroseptal or midseptal accessory pathways in children: a 2-year single-center experience. Pacing Clin Electrophysiol 41(9):1123–1128. https://doi.org/10.1111/pace.13438
Akdeniz C, Ergul Y, Kiplapinar N, Tuzcu V (2013) Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants. Cardiol J 20(3):241–246. https://doi.org/10.5603/CJ.2013.0068
Aiyagari R, Saarel EV, Etheridge SP, Bradley DJ, Dick M, Fischbach PS (2005) Radiofrequency ablation for supraventricular tachycardia in children < or =15 kg is safe and effective. Pediatr Cardiol 26(5):622–626. https://doi.org/10.1007/s00246-004-0849-4
Acknowledgments
The authors thank Dr Zhang Yan for revising English writing.
Author information
Authors and Affiliations
Contributions
YZ performed the literature search and drafted the manuscript. XL revised the manuscript and gave the final approval.
Corresponding author
Ethics declarations
This review did not involve either human or animal subjects. Therefore, informed consent was not required.
Conflict of interest
The authors declare that there are no conflict of interest.
Additional information
Communicated by Peter de Winter
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, Y., Li, Xm. Pre-excitation cardiac problems in children: recognition and treatment. Eur J Pediatr 179, 1197–1204 (2020). https://doi.org/10.1007/s00431-020-03701-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-020-03701-9